US Stock MarketDetailed Quotes

ARWR Arrowhead Pharmaceuticals

Watchlist
  • 25.220
  • -0.850-3.26%
Trading Dec 4 10:47 ET
3.14BMarket Cap-5044P/E (TTM)

Arrowhead Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-200.77%-462.85M
-429.26%-137.22M
-455.51%-115.42M
-191.68%-92.38M
-56.05%-117.84M
-13.05%-153.89M
62.28%-25.93M
69.81%-20.78M
-150.49%-31.67M
-23.17%-75.52M
Net income from continuing operations
-191.34%-609.69M
-56.14%-173.34M
-67.08%-173.98M
-366.37%-127M
-223.78%-135.38M
-18.57%-209.28M
-29.17%-111.02M
-44.53%-104.13M
7.46%47.68M
33.50%-41.81M
Operating gains losses
--80K
--160K
--0
--0
---80K
----
----
----
----
----
Depreciation and amortization
48.84%18.6M
30.22%5.03M
45.97%4.78M
69.54%4.53M
58.53%4.26M
19.88%12.49M
45.08%3.86M
26.29%3.28M
2.89%2.67M
4.51%2.69M
Other non cash items
76.54%32.35M
178.35%14.65M
-1.26%5.09M
43.27%7.25M
88.38%5.37M
--18.33M
--5.26M
206.29%5.16M
730.38%5.06M
1,117.50%2.85M
Change In working capital
148.68%25.09M
-86.47%7.95M
-55.93%24.64M
103.15%3.37M
81.67%-10.87M
47.56%-51.55M
513.17%58.77M
239.12%55.92M
-473.48%-106.91M
-135.10%-59.32M
-Change in receivables
--0
--0
--0
--0
--0
-84.06%1.41M
206.40%1.25M
6,225.42%68.19M
-2,459.30%-29.87M
-477.61%-38.16M
-Change in prepaid assets
-114.34%-1.66M
100.50%82K
-88.20%897K
-109.15%-895K
-116.60%-1.75M
160.15%11.6M
-56.47%-16.31M
236.91%7.6M
441.60%9.78M
2,439.78%10.53M
-Change in payables and accrued expense
47.40%26.58M
-76.26%10.71M
474.18%24.28M
132.18%3.64M
-29.97%-12.06M
61.57%18.03M
246.74%45.11M
3.06%-6.49M
-190.35%-11.32M
-20.78%-9.28M
-Change in other current liabilities
----
----
----
----
579.07%3.8M
----
----
----
----
143.04%559K
-Change in other working capital
100.21%174K
-96.60%1.04M
70.97%-4.42M
105.89%4.42M
96.23%-866K
16.58%-82.59M
295.33%30.55M
46.51%-15.21M
-172.68%-74.95M
16.25%-22.98M
Cash from discontinued investing activities
Operating cash flow
-200.77%-462.85M
-429.26%-137.22M
-455.51%-115.42M
-191.68%-92.38M
-56.05%-117.84M
-13.05%-153.89M
62.28%-25.93M
69.81%-20.78M
-150.49%-31.67M
-23.17%-75.52M
Investing cash flow
Cash flow from continuing investing activities
-336.87%-420.07M
-830.68%-222.92M
170.16%6.95M
-645.70%-268.94M
180.35%64.84M
-1,675.06%-96.16M
-16.29%30.51M
-116.16%-9.91M
48.30%-36.07M
-141.71%-80.69M
Net PPE purchase and sale
19.96%-141.47M
61.99%-24.29M
69.00%-14.45M
-24.75%-34.08M
-76.44%-68.66M
-234.88%-176.74M
-95.37%-63.91M
-388.73%-46.61M
-474.79%-27.31M
-573.43%-38.91M
Net investment purchase and sale
-445.74%-278.6M
-310.38%-198.63M
-41.69%21.4M
-2,583.83%-234.86M
419.50%133.5M
70.15%80.58M
36.53%94.42M
-48.17%36.7M
86.54%-8.75M
-51.35%-41.78M
Cash from discontinued investing activities
Investing cash flow
-336.87%-420.07M
-830.68%-222.92M
170.16%6.95M
-645.70%-268.94M
180.35%64.84M
-1,675.06%-96.16M
-16.29%30.51M
-116.16%-9.91M
48.30%-36.07M
-141.71%-80.69M
Financing cash flow
Cash flow from continuing financing activities
244.01%870.52M
47,292.08%389.09M
4,335.48%50.39M
82,741.73%430.78M
-99.89%267K
288.20%253.05M
-3.98%821K
-98.13%1.14M
-71.83%520K
13,193.16%250.58M
Net issuance payments of debt
--392M
----
----
----
----
--0
----
----
----
----
Net common stock issuance
--429.27M
--0
--0
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
-21.75%2.39M
-72.84%223K
-65.93%387K
190.77%1.51M
-53.65%267K
-41.13%3.05M
-3.98%821K
89.33%1.14M
-71.83%520K
-69.44%576K
Net other financing activities
-81.25%46.87M
---3.13M
----
----
----
316.67%250M
--0
--0
--0
--250M
Cash from discontinued financing activities
Financing cash flow
244.01%870.52M
47,292.08%389.09M
4,335.48%50.39M
82,741.73%430.78M
-99.89%267K
288.20%253.05M
-3.98%821K
-98.13%1.14M
-71.83%520K
13,193.16%250.58M
Net cash flow
Beginning cash position
2.67%110.89M
-34.12%69.4M
-5.38%127.7M
-71.22%58.22M
2.67%110.89M
-41.44%108.01M
-24.46%105.33M
56.19%134.96M
120.83%202.25M
-41.44%108.01M
Current changes in cash
-512.33%-12.4M
435.71%28.95M
-96.58%-58.08M
203.34%69.46M
-155.88%-52.73M
103.94%3.01M
117.19%5.4M
-155.68%-29.55M
-1,197.61%-67.22M
201.68%94.37M
Effect of exchange rate changes
3,540.16%4.2M
2,733.99%4.34M
-182.28%-223K
135.14%26K
147.54%58K
-82.09%-122K
5,000.00%153K
-146.88%-79K
-7,500.00%-74K
-212.82%-122K
End cash Position
-7.40%102.69M
-7.40%102.69M
-34.12%69.4M
-5.38%127.7M
-71.22%58.22M
2.67%110.89M
2.67%110.89M
-24.46%105.33M
56.19%134.96M
120.83%202.25M
Free cash flow
-82.78%-604.32M
-79.78%-161.51M
-92.73%-129.87M
-114.38%-126.45M
-62.98%-186.5M
-75.02%-330.63M
11.45%-89.83M
14.00%-67.38M
-201.74%-58.99M
-70.57%-114.43M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -200.77%-462.85M-429.26%-137.22M-455.51%-115.42M-191.68%-92.38M-56.05%-117.84M-13.05%-153.89M62.28%-25.93M69.81%-20.78M-150.49%-31.67M-23.17%-75.52M
Net income from continuing operations -191.34%-609.69M-56.14%-173.34M-67.08%-173.98M-366.37%-127M-223.78%-135.38M-18.57%-209.28M-29.17%-111.02M-44.53%-104.13M7.46%47.68M33.50%-41.81M
Operating gains losses --80K--160K--0--0---80K--------------------
Depreciation and amortization 48.84%18.6M30.22%5.03M45.97%4.78M69.54%4.53M58.53%4.26M19.88%12.49M45.08%3.86M26.29%3.28M2.89%2.67M4.51%2.69M
Other non cash items 76.54%32.35M178.35%14.65M-1.26%5.09M43.27%7.25M88.38%5.37M--18.33M--5.26M206.29%5.16M730.38%5.06M1,117.50%2.85M
Change In working capital 148.68%25.09M-86.47%7.95M-55.93%24.64M103.15%3.37M81.67%-10.87M47.56%-51.55M513.17%58.77M239.12%55.92M-473.48%-106.91M-135.10%-59.32M
-Change in receivables --0--0--0--0--0-84.06%1.41M206.40%1.25M6,225.42%68.19M-2,459.30%-29.87M-477.61%-38.16M
-Change in prepaid assets -114.34%-1.66M100.50%82K-88.20%897K-109.15%-895K-116.60%-1.75M160.15%11.6M-56.47%-16.31M236.91%7.6M441.60%9.78M2,439.78%10.53M
-Change in payables and accrued expense 47.40%26.58M-76.26%10.71M474.18%24.28M132.18%3.64M-29.97%-12.06M61.57%18.03M246.74%45.11M3.06%-6.49M-190.35%-11.32M-20.78%-9.28M
-Change in other current liabilities ----------------579.07%3.8M----------------143.04%559K
-Change in other working capital 100.21%174K-96.60%1.04M70.97%-4.42M105.89%4.42M96.23%-866K16.58%-82.59M295.33%30.55M46.51%-15.21M-172.68%-74.95M16.25%-22.98M
Cash from discontinued investing activities
Operating cash flow -200.77%-462.85M-429.26%-137.22M-455.51%-115.42M-191.68%-92.38M-56.05%-117.84M-13.05%-153.89M62.28%-25.93M69.81%-20.78M-150.49%-31.67M-23.17%-75.52M
Investing cash flow
Cash flow from continuing investing activities -336.87%-420.07M-830.68%-222.92M170.16%6.95M-645.70%-268.94M180.35%64.84M-1,675.06%-96.16M-16.29%30.51M-116.16%-9.91M48.30%-36.07M-141.71%-80.69M
Net PPE purchase and sale 19.96%-141.47M61.99%-24.29M69.00%-14.45M-24.75%-34.08M-76.44%-68.66M-234.88%-176.74M-95.37%-63.91M-388.73%-46.61M-474.79%-27.31M-573.43%-38.91M
Net investment purchase and sale -445.74%-278.6M-310.38%-198.63M-41.69%21.4M-2,583.83%-234.86M419.50%133.5M70.15%80.58M36.53%94.42M-48.17%36.7M86.54%-8.75M-51.35%-41.78M
Cash from discontinued investing activities
Investing cash flow -336.87%-420.07M-830.68%-222.92M170.16%6.95M-645.70%-268.94M180.35%64.84M-1,675.06%-96.16M-16.29%30.51M-116.16%-9.91M48.30%-36.07M-141.71%-80.69M
Financing cash flow
Cash flow from continuing financing activities 244.01%870.52M47,292.08%389.09M4,335.48%50.39M82,741.73%430.78M-99.89%267K288.20%253.05M-3.98%821K-98.13%1.14M-71.83%520K13,193.16%250.58M
Net issuance payments of debt --392M------------------0----------------
Net common stock issuance --429.27M--0--0----------0--0--0--------
Proceeds from stock option exercised by employees -21.75%2.39M-72.84%223K-65.93%387K190.77%1.51M-53.65%267K-41.13%3.05M-3.98%821K89.33%1.14M-71.83%520K-69.44%576K
Net other financing activities -81.25%46.87M---3.13M------------316.67%250M--0--0--0--250M
Cash from discontinued financing activities
Financing cash flow 244.01%870.52M47,292.08%389.09M4,335.48%50.39M82,741.73%430.78M-99.89%267K288.20%253.05M-3.98%821K-98.13%1.14M-71.83%520K13,193.16%250.58M
Net cash flow
Beginning cash position 2.67%110.89M-34.12%69.4M-5.38%127.7M-71.22%58.22M2.67%110.89M-41.44%108.01M-24.46%105.33M56.19%134.96M120.83%202.25M-41.44%108.01M
Current changes in cash -512.33%-12.4M435.71%28.95M-96.58%-58.08M203.34%69.46M-155.88%-52.73M103.94%3.01M117.19%5.4M-155.68%-29.55M-1,197.61%-67.22M201.68%94.37M
Effect of exchange rate changes 3,540.16%4.2M2,733.99%4.34M-182.28%-223K135.14%26K147.54%58K-82.09%-122K5,000.00%153K-146.88%-79K-7,500.00%-74K-212.82%-122K
End cash Position -7.40%102.69M-7.40%102.69M-34.12%69.4M-5.38%127.7M-71.22%58.22M2.67%110.89M2.67%110.89M-24.46%105.33M56.19%134.96M120.83%202.25M
Free cash flow -82.78%-604.32M-79.78%-161.51M-92.73%-129.87M-114.38%-126.45M-62.98%-186.5M-75.02%-330.63M11.45%-89.83M14.00%-67.38M-201.74%-58.99M-70.57%-114.43M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------